Vanguard Group Inc. Reduces Stake in Integer Holdings Co. (NYSE:ITGR)

Vanguard Group Inc. reduced its position in Integer Holdings Co. (NYSE:ITGR) by 1.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,802,706 shares of the medical equipment provider’s stock after selling 41,286 shares during the period. Vanguard Group Inc. owned approximately 11.38% of Integer worth $376,772,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of ITGR. Public Employees Retirement Association of Colorado boosted its stake in shares of Integer by 3,260.1% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock worth $28,281,000 after buying an additional 276,944 shares during the last quarter. Norges Bank purchased a new position in Integer during the fourth quarter valued at $18,697,000. FMR LLC lifted its position in Integer by 12.8% during the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider’s stock valued at $67,759,000 after purchasing an additional 97,851 shares in the last quarter. North Growth Management Ltd. purchased a new position in Integer during the fourth quarter valued at $9,155,000. Finally, Congress Asset Management Co. MA lifted its position in Integer by 12.5% during the fourth quarter. Congress Asset Management Co. MA now owns 421,524 shares of the medical equipment provider’s stock valued at $41,765,000 after purchasing an additional 46,776 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Integer

In other news, VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total value of $171,000.00. Following the sale, the vice president now directly owns 2,813 shares of the company’s stock, valued at $320,682. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Andrew Senn sold 5,000 shares of Integer stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total value of $565,700.00. Following the completion of the transaction, the senior vice president now owns 4,658 shares in the company, valued at $527,006.12. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total value of $171,000.00. Following the completion of the transaction, the vice president now owns 2,813 shares of the company’s stock, valued at approximately $320,682. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,936 shares of company stock valued at $2,130,937. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Truist Financial assumed coverage on Integer in a research report on Wednesday, May 15th. They set a “buy” rating and a $137.00 target price on the stock. KeyCorp lifted their target price on Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. Benchmark reiterated a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Friday, May 10th. Citigroup raised their price target on Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a report on Wednesday, May 22nd. Finally, CL King started coverage on Integer in a report on Thursday, March 14th. They set a “buy” rating and a $137.00 price target on the stock. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $128.00.

Integer Trading Down 0.2 %

Shares of ITGR stock opened at $114.53 on Friday. Integer Holdings Co. has a 12-month low of $69.40 and a 12-month high of $123.99. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. The stock’s 50-day moving average price is $116.91 and its 200-day moving average price is $110.06. The stock has a market capitalization of $3.84 billion, a price-to-earnings ratio of 39.63, a price-to-earnings-growth ratio of 1.69 and a beta of 1.16.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.02. Integer had a return on equity of 11.25% and a net margin of 6.01%. The firm had revenue of $414.80 million for the quarter, compared to analysts’ expectations of $412.78 million. During the same period in the previous year, the firm posted $0.87 earnings per share. The business’s revenue was up 9.5% compared to the same quarter last year. Equities research analysts predict that Integer Holdings Co. will post 5.27 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.